ARTV
Artiva Biotherapeutics, Inc. Common Stock
NASDAQ: ARTV · HEALTHCARE · BIOTECHNOLOGY
$10.24
+17.43% today
Updated 2026-04-30
Market cap
$255.08M
P/E ratio
—
P/S ratio
8.11x
EPS (TTM)
$-3.43
Dividend yield
—
52W range
$1 – $15
Volume
0.3M
Artiva Biotherapeutics, Inc. Common Stock (ARTV) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-13.54M | $-15.30M | $-50.83M | $-47.43M | $-55.03M | $-76.75M |
| Capital expenditures | $284000.00 | $1.72M | $6.30M | $3.26M | $642000.00 | $2.59M |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $297000.00 | $4.31M | $6.58M | $7.05M | $6.98M | $6.82M |
| Free cash flow | $-13.82M | $-17.03M | $-57.13M | $-50.69M | $-55.67M | $-79.34M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |